Neuroprosthetics

Neuroprosthetics is the engineering discipline concerned with devices that exchange signals directly with the nervous system in order to replace a function the nervous system has lost. It spans devices in routine clinical use — the Cochlear implant, the spinal cord stimulator, Deep brain stimulation — and devices that exist only in single-patient research studies, such as cortical arrays that restore a sense of touch. The unifying problem is not electronics but interface: how to place a durable transducer against excitable tissue that reacts to its presence, and how to encode information in a form neurons will accept.

§Scope and taxonomy

Four families are usually distinguished, though real devices increasingly cross the boundaries.

Sensory prostheses convert an external stimulus into neural activity. The cochlear implant and the Retinal implants and visual prostheses are the archetypes; vestibular implants for bilateral vestibular loss have reached small human trials. These devices must solve an encoding problem, because the natural code of the sense organ is not reproducible with electrodes.

Motor prostheses read intent and act on it. Cortical systems for people with paralysis fall under Brain–computer interface; peripheral systems that read muscle activity fall under Myoelectric prosthetics; functional electrical stimulation drives the user's own paralysed muscles or spinal circuitry rather than an external actuator.

Autonomic and organ-directed devices are numerically the largest category and receive the least attention. Sacral neuromodulation for bladder dysfunction, vagus nerve stimulation for epilepsy and for rehabilitation after stroke, phrenic pacing for ventilator dependence, and spinal cord stimulation for chronic pain together account for far more implants than every cortical device combined.

Cognitive prostheses attempt to restore a computation rather than a signal path. The only serious example is the hippocampal Memory prosthesis, and it remains at the proof-of-concept stage.

§How a neuroprosthesis works

Every device is a loop with four parts, and each part fails differently.

The transducer couples electrical or optical energy to tissue. Choices range from penetrating microelectrode arrays such as the Utah array, through surface arrays used in Electrocorticography interfaces, to nerve cuffs, intrafascicular electrodes, and the endovascular approach of the Stentrode. Closer coupling means more information per channel and more tissue damage.

The front end amplifies microvolt signals in the presence of stimulation artefacts thousands of times larger, and does so within a power budget that will not heat the surrounding tissue by more than a fraction of a degree.

The algorithm converts signals into commands or converts sensor data into stimulation patterns. On the read side this is Neural decoding, which has improved faster than the hardware. On the write side it is an encoding problem with no equivalent body of theory.

The actuator is a robotic limb, a synthesized voice, a stimulator on the user's own spinal cord, or a pattern of current in a sensory nucleus. Systems that both read and write are called bidirectional, and they are where the field's hardest problems live.

§Development history

1. 1957–1961
   Direct stimulation of a sense
   Djourno and Eyriès stimulate the auditory nerve of a deaf patient; William House begins implanting single-channel cochlear devices in Los Angeles.
2. 1968
   Cortical visual prosthesis
   Brindley and Lewin evoke patterned phosphenes from an electrode array over the occipital cortex of a blind volunteer.
3. 1987–1997
   Deep brain stimulation becomes clinical
   Chronic high-frequency thalamic stimulation for tremor moves from a Grenoble case series to regulatory approval.
4. 2004–2006
   Human cortical motor decoding
   A participant with tetraplegia in the BrainGate pilot controls a cursor and a prosthetic hand with a penetrating array.
5. 2014–2016
   Touch written back in
   Peripheral nerve cuffs in amputees and intracortical microstimulation of somatosensory cortex in a participant with spinal cord injury evoke localized tactile percepts.
6. 2018–2023
   Spinal interfaces restore walking
   Targeted epidural stimulation restores stepping after spinal cord injury; a 2023 system links a cortical implant to a spinal stimulator to give volitional control of walking.
7. 2020s
   Commercial implants enter trials
   Multiple companies run early feasibility studies of implanted interfaces, and adaptive sensing-and-stimulating devices reach the market for movement disorders.

§Current state

The clinically settled devices restore hearing, suppress movement-disorder symptoms, manage pain, and control bladder and bowel function. They are unglamorous, well reimbursed in wealthy countries, and improving incrementally.

The research frontier is bidirectional restoration after paralysis and amputation. Three results define it. Intracortical microstimulation of human somatosensory cortex produces tactile sensations that a participant localizes to specific fingers of a paralysed hand, and adding that feedback roughly halved the time needed to complete an object-transfer task with a robotic arm.¹² Implanted electrodes in residual peripheral nerves evoke graded touch in amputees and, combined with skeletal attachment through Osseointegration, have supported prostheses used at home for years.³ And epidural spinal stimulation, targeted to the dorsal roots that recruit specific leg muscle groups, restores stepping in people with severe spinal cord injury.⁴ A cortical implant wired to such a stimulator gave one participant volitional, thought-driven walking, and produced neurological recovery that persisted with the system switched off.

Each of these involves single-digit numbers of participants. A device cleared in the United States in late 2024 delivers non-invasive transcutaneous spinal stimulation to improve hand and arm strength after cervical injury, and represents the first of this generation to reach the market.

§The feedback problem

Reading intent out of the nervous system is comparatively tractable, because a decoder can be trained on labelled attempts and improved offline without touching the tissue. Writing information in is harder for reasons that are structural rather than temporary.

An electrode excites every axon within its field indiscriminately, including axons of passage belonging to unrelated circuits. Natural sensory input arrives as spatiotemporally patterned activity across specific cell types; electrical stimulation produces synchronous activation of a sphere of tissue, which the brain has never encountered and has no code for. Percepts evoked this way are describable but unnatural: pressure, tingling, or a vague spot of light rather than texture, temperature, or shape. Repeated stimulation drives adaptation, so amplitude must be modulated to maintain a stable percept. And every stimulation pulse saturates the recording amplifiers, which is why bidirectional devices need artefact-rejection schemes that discard part of the signal they were built to collect.

Two approaches attack the specificity limit. Biomimetic stimulation shapes pulse trains to imitate the dynamics of natural afferent firing rather than delivering constant-amplitude trains, which improves the naturalness of evoked touch. Optogenetics achieves genuine cell-type specificity in animals but requires gene delivery and implanted light sources; no human neuroprosthesis uses it.

Why this asymmetry matters

A motor prosthesis that reads well and writes badly is still useful, because vision substitutes for missing touch. A sensory prosthesis has nothing to substitute for a bad write channel, which is why hearing and vision restoration have plateaued at low information rates while motor decoding has kept improving.

§Limitations and failure modes

Chronic implants fail in predictable ways. Penetrating electrodes provoke a foreign-body response: microglia activate, astrocytes encapsulate the shank, and neurons retreat from the recording tip, so signal yield declines over months to years. Insulation absorbs water and delaminates; thin metal traces corrode; hermetic feedthroughs leak. Percutaneous connectors, still standard in academic systems, are an infection route and tether the user to a laboratory.

Beyond the hardware, three limits recur. Decoders drift as the recorded population changes, requiring recalibration. Almost all headline performance is measured with a technician present in a controlled setting, and degrades outside it. And the number of independent control or perceptual dimensions a person can use saturates well below the electrode count, for the same reason in every modality: current spread makes nearby channels non-independent.

§Ethics and access

Implanted neurotechnology raises questions that ordinary medical devices do not. Recorded neural activity supports inferences the user did not intend to disclose, the concern formalized under Mental privacy and addressed legislatively under Neurorights. Devices that modulate mood or motivation raise questions about authorship of action. And a device implanted for therapy in a person who cannot easily have it removed creates an asymmetric dependence on the manufacturer's continued existence — an exposure demonstrated when retinal implant support was withdrawn from several hundred patients.

Access follows wealth rather than need. Cochlear implantation rates differ by more than an order of magnitude between high- and low-income countries, and every newer device is more expensive. The distributional pattern examined in Access and inequality is not hypothetical here; it is the current state of the most successful neuroprosthesis ever built.

Where restoration shades into Human enhancement is a live boundary rather than a settled line. Devices such as those catalogued in Sensory augmentation use the same interfaces to add capacities rather than restore them, and speculative uses such as Brain-to-brain interfaces communication borrow the vocabulary of clinical neuroprosthetics while resting on far weaker demonstrations.

§Outlook

Two trends look likely to shape the next decade. Materials and packaging are improving faster than algorithms — thin-film flexible arrays, carbon-fibre electrodes, and fully implanted wireless systems address the specific failure modes that have limited chronic recording, and commercial programmes at Neuralink, Synchron, and others are funding that engineering at a scale academic laboratories never could. Miniaturized wireless nodes of the kind described under Neural dust and ultrasonic implants would change the placement calculus if they can be made to work at cortical depth.

The competing trajectory is biological. Regenerative approaches under Limb regeneration and cell replacement therapies would remove the need for an interface entirely in some indications, and external assistive devices such as the Powered exoskeletons avoid implantation altogether. Which path wins depends on an unresolved empirical question: whether the write-channel problem yields to better encoding and better electrodes, or whether artificial stimulation is permanently limited to coarse, unnatural percepts that the brain can learn to use but never to interpret as its own.

§See also

• Brain–computer interface
• Cochlear implant
• Retinal implants and visual prostheses
• Deep brain stimulation
• Myoelectric prosthetics
• Speech neuroprosthesis
• Memory prosthesis
• Non-invasive neuromodulation

§References